Zhifeng Li1, Shaopeng Huang2, Rui Yang3, Jieyuan Li1, Guoqiang Chen1. 1. Department of General Medicine, Foshan First People's Hospital Foshan 528000, Guangdong Province, China. 2. Department of General Medicine, No. 7 People's Hospital of Nanhai District Foshan 528248, Guangdong Province, China. 3. Department of General Medicine, Zhujiang Hospital of Southern Medical University Guangzhou 510280, Guangdong Province, China.
Abstract
OBJECTIVE: Non-ST-segment elevation myocardial infarction (NSTEMI) is prevalent in patients with diabetes mellitus (DM). The long-term follow-up outcomes of this group of patients remain misunderstood. This study was aimed at investigating long-term follow-up outcomes of diabetic patients discharged with NSTEMI. METHODS: All diabetic patients discharged with MI were recruited and followed up in this study. Patients who had elevated serum troponin, but no ST segment elevation were considered as NSTEMI. A structured follow-up was conducted at 3 months, 6 months, 12 months, and 24 months. Independent risk factors for all-cause and cardiovascular mortality were analyzed. RESULTS: A total of 743 diabetic patients with MI enrolled for analysis, with 132 patients being recognized as NSTEMI. The mean age was 70.4±8.3 years. The mean follow-up was 21.3±6.1 months. NSTEMI (hazard ratio [HR] 1.55, 95% confidence interval [CI] 1.08-2.23), age ≥75 years (HR 1.17, 95% CI 1.04-1.31), hypertension (HR 1.51, 95% CI 1.03-2.21), heart failure (HF) (HR 3.23, 95% CI 2.28-4.57), and previous MI (HR 2.01, 95% CI 1.44-2.79) were independent risk factors for all-cause mortality. Administration of beta-blocker (HR 0.62, 95% CI 0.45-0.85) was associated with a lower incidence of all-cause mortality. Predictors for cardiovascular mortality included elderly, hypertension, HF, previous MI, and MI with atypical chest pain. CONCLUSIONS: Multiple risk factors contribute to a higher incidence of composite outcomes in diabetic patients with MI. STEMI poses a greater threat to adverse events, which warrants more investigations. AJTR
OBJECTIVE: Non-ST-segment elevation myocardial infarction (NSTEMI) is prevalent in patients with diabetes mellitus (DM). The long-term follow-up outcomes of this group of patients remain misunderstood. This study was aimed at investigating long-term follow-up outcomes of diabetic patients discharged with NSTEMI. METHODS: All diabetic patients discharged with MI were recruited and followed up in this study. Patients who had elevated serum troponin, but no ST segment elevation were considered as NSTEMI. A structured follow-up was conducted at 3 months, 6 months, 12 months, and 24 months. Independent risk factors for all-cause and cardiovascular mortality were analyzed. RESULTS: A total of 743 diabetic patients with MI enrolled for analysis, with 132 patients being recognized as NSTEMI. The mean age was 70.4±8.3 years. The mean follow-up was 21.3±6.1 months. NSTEMI (hazard ratio [HR] 1.55, 95% confidence interval [CI] 1.08-2.23), age ≥75 years (HR 1.17, 95% CI 1.04-1.31), hypertension (HR 1.51, 95% CI 1.03-2.21), heart failure (HF) (HR 3.23, 95% CI 2.28-4.57), and previous MI (HR 2.01, 95% CI 1.44-2.79) were independent risk factors for all-cause mortality. Administration of beta-blocker (HR 0.62, 95% CI 0.45-0.85) was associated with a lower incidence of all-cause mortality. Predictors for cardiovascular mortality included elderly, hypertension, HF, previous MI, and MI with atypical chest pain. CONCLUSIONS: Multiple risk factors contribute to a higher incidence of composite outcomes in diabetic patients with MI. STEMI poses a greater threat to adverse events, which warrants more investigations. AJTR
Authors: Manesh R Patel; Anita Y Chen; Eric D Peterson; L Kristin Newby; Charles V Pollack; Ralph G Brindis; C Michael Gibson; Neal S Kleiman; Jorge F Saucedo; Deepak L Bhatt; W Brian Gibler; E Magnus Ohman; Robert A Harrington; Matthew T Roe Journal: Am Heart J Date: 2006-10 Impact factor: 4.749
Authors: María Cristina González-Cambeiro; Andrea López-López; Emad Abu-Assi; Sergio Raposeiras-Roubín; Carlos Peña-Gil; José García-Acuña; Ramón González-Juanatey Journal: Rev Port Cardiol Date: 2016-11-17 Impact factor: 1.374
Authors: Noora Ristiniemi; Juha Lund; Risto Tertti; Anders Christensson; Tuomo Ilva; Pekka Porela; Kari Pulkki; Kim Pettersson Journal: Clin Biochem Date: 2012-02-27 Impact factor: 3.281
Authors: Barbara D Lawson; M Zubair Khan; Richard H Cooke; J Emilio Exaire; Luis A Guzman; Zachary M Gertz Journal: J Invasive Cardiol Date: 2018-12-15 Impact factor: 2.022